Rapid antigen test based on gold nanoparticles embedded with highly sensitive surface-enhanced Raman scattering probes for detecting antigen concentrations below the visual detection limit
Microchimica Acta · 2025
DOI: 10.1007/s00604-025-07179-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, 2025. Verfasst von Hyeon Ho Shin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Analysis Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, 34114, Republic of Korea. Hauptthemen laut MEDLINE: Gold, Metal Nanoparticles, Spectrum Analysis, Raman, SARS-CoV-2. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Ministry of Trade, Industry and Energy.
Abstract (Originalsprache)
The COVID-19 pandemic has proven that people expect medically high accuracy, sensitivity, and rapid testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection. These needs have led to developing various testing methods and platforms to replace reverse transcription polymerase chain reaction (RT-PCR), the golden standard in diagnostics. Rapid antigen testing (RAT) using gold nanoparticles (AuNPs) has been developed to compensate for the shortcomings of RT-PCR. However, RAT still shows less sensitive results because it is judged by sight only. Here, we applied gold-nanobridged nanogap particles (Au-NNPs) to conventional lateral flow assay (LFA) technology for high-sensitivity testing of samples containing antigen concentration below the visual detection limit through surface-enhanced Raman scattering (SERS) signal detection. By using Raman dye-embedded Au-NNPs showing susceptible Raman signals instead of simply using gold nanoparticles, the sensitivity of the conventional RAT has been significantly increased. Therefore, it was possible to increase the sensitivity of RAT combined with simplicity and rapidity of the approach. These developments will lead to characterization applications of bio-nanotechnology and nanoparticles for health and social issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Analysis Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, 34114, Republic of Korea.
- Department of Electronic Engineering, Hanyang University, Seoul, 04763, Republic of Korea.
- Department of Chemistry, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
- Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, 34114, Republic of Korea.
- Chemical Analysis Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, 34114, Republic of Korea. mschoi@krict.re.kr.
- Chemical Analysis Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, 34114, Republic of Korea. shnam@krict.re.kr.
ORCID-Profile: Hyeon Ho Shin, Minseo Kim, Yeongchang Goh, Jin Soo Shin, Doo-Hyun Ko, Minsuk Choi, Sang Hwan Nam
Förderung
- Ministry of Trade, Industry and Energy
Zitieren
APA
Shin, H. H., Kim, M., Goh, Y., Shin, J. S., Ko, D. H., Choi, M., & Nam, S. H. (2025). Rapid antigen test based on gold nanoparticles embedded with highly sensitive surface-enhanced Raman scattering probes for detecting antigen concentrations below the visual detection limit. Microchimica Acta. https://doi.org/10.1007/s00604-025-07179-w
Vancouver
Shin HH, Kim M, Goh Y, Shin JS, Ko DH, Choi M, et al. Rapid antigen test based on gold nanoparticles embedded with highly sensitive surface-enhanced Raman scattering probes for detecting antigen concentrations below the visual detection limit. Microchimica Acta. 2025. doi:10.1007/s00604-025-07179-w
BibTeX
@article{Shin2025,
author = {Shin, Hyeon Ho and Kim, Minseo and Goh, Yeongchang and Shin, Jin Soo and Ko, Doo-Hyun and Choi, Minsuk and Nam, Sang Hwan},
title = {Rapid antigen test based on gold nanoparticles embedded with highly sensitive surface-enhanced Raman scattering probes for detecting antigen concentrations below the visual detection limit},
journal = {Microchimica Acta},
year = {2025},
doi = {10.1007/s00604-025-07179-w}
}
EUVIMED